Get 50% OFF This Monsoon!

Advertisement
AdvertisementAdvertisement
logo

Zota Health Care

ZOTA
Small Cap
(%) 1D
no_data

No Data Available

1D1W1M3M6M1YMAX

Investor Sentiment

50%50%
Bullish
Bearish
Advertisement
AdvertisementAdvertisement

Zota Health Care Share price and Fundamental Analysis

View All Details
View All Details
Zota Health Care Limited is a renowned pharmaceutical company that manufactures, markets, and exports pharmaceutical, ayurvedic, nutraceutical, and over-the-counter (OTC) products. The Company was incorporated in July 12, 2000 and is based out of Surat, Gujarat. The Company meets the requirements of millions of people by increasing access to high-quality, affordable medicines for chronic illnesses including heart disease, diabetes, thyroid disease, and others, giving India's pharmaceutical industry a boost.
Company Incorporation2000
ChairmanKetankumar Zota
Head QuartersNA
Previous NameNA

Key Metrics

Market Cap (Cr)
2,949.33
PE Ratio
0
Industry P/E
34.61
PEG Ratio
0
ROE
-21.81%
ROCE
-10.73%
ROA
-16.03%
Total Debt (Cr)
106.76
Debt to Equity
0.67
Dividend Yield
0.09%
EPS
0
Book Value & P/B
83.02 x 12.07
Face Value
10
Outstanding Shares(Cr)
2.94
Current Ratio
2.77
EV to Sales
12.45

Included In

+More

Stock Returns

1 Week+0.18%
1 Month+14.97%
6 Months+74.01%
1 Year+113.88%
3 Years+268.23%
5 Years+607.73%

CAGR

1 Year CAGR

Revenue Growth

+28.96%

Net Profit Growth

+148.54%

Operating Profit Growth

-11.39%

Dividend Growth

0%

Stock Returns CAGR

+113.88%
no_data

No Stocks

Smart Score

2.2
icn

Unlock Smart Score

See Detailed Analysis & Insights

icn

Unlock Insights

See Detailed Analysis & Insights

Technicals

Returns Calculator

If you would have invested
In 5 years the current value would be
NaNCRNaNCR( %)

Research Report

No Research Report

View Other Reports >

Corporate Action

Board-Meetings
Board-Meetings
Dividends
Bonus
Splits
Right-issues
AGM-EGM
Bulk-Deal
Block-Deal

Financials

Half Yearly Statement

/ View Standalone
PARTICULARS

Total Revenue

Total Expenses

Operating Expense

Operating Profit

Interest

Depreciation & Amortization

Profit Before Tax

Tax

Profit after tax

Adj EPS in Rs - Basic

Adj EPS in Rs - Diluted

Profit and Loss Statement

/ View Standalone
Credit Rating
Director Report
Chairman Report
Auditor Report

Balance sheet

/ View Standalone

Cashflow Statement

/ View Standalone
Apr 25

Promoters : 58.11%

FIIs : 3.60%

DIIs : 0.00%

Public : 38.29%

Promoter
FII/FPI
DII
Public
FII Shareholding Increased by 2.73% to 3.6% in April 2025 Qtr
Promoter Shareholding Decreased by 1.61% to 58.11% in April 2025 Qtr

Top Shareholders

View all Share Holders

Key Ratios

Profitability
Valuation
Liquidity

ROE

Avg ROE (3 Yrs) : NaN%

ROCE

Avg ROCE (3 Yrs) : NaN%

ROA

Avg ROA (3 Yrs) : NaN%

NPM

Avg NPM (3 Yrs) : NaN%

Dividend History

Zota Health Care Competitors

Sector
Industry

Company Name

MCap(TTM)

PE(TTM)

P/B(TTM)

ROE(TTM)

D/E

Current Ratio(TTM)

5 Year FactSheet

Profitability
Profitability
Growth Ratios
Valuation Ratios
Cashflow Ratios
Debt and Liquidity
Efficiency Ratios

Documents

Annual Reports
Con-Call

News

Zota Health Care Management and History

Company Management

icn

Unlock Management Data

See Detailed Analysis & Insights

Company History

Zota Health Care Limited is a renowned pharmaceutical company that manufactures, markets, and exports pharmaceutical, ayurvedic, nutraceutical, and over-the-counter (OTC) products. The Company was incorporated in July 12, 2000 and is based out of Surat, Gujarat. The Company meets the requirements of millions of people by increasing access to high-quality, affordable medicines for chronic illnesses including heart disease, diabetes, thyroid disease, and others, giving India's pharmaceutical industry a boost.

The Company has three business verticals: Marketing-a traditional business vertical, and driving business verticals - Exports and Retail harmacy Chain. Through its chain, Davaindia, the largest private-sector generic pharmacy chain, the Company is making strong inroads into the generic retail pharmacy business. The Company's state-of-the-art manufacturing facility at Sachin SEZ serves customers in more than 30 countries. Davaindia is a retail generic pharmacy chain whose core value proposition is providing quality generic medicines at substantial discounts, i.e. 30% to 90%, to their branded equivalents. Davaindia focuses on private-label products in the medicinal, OTC, and ayurvedic categories, with a greater emphasis on chronic therapies and ailments.

The Marketing business vertical involves the direct distribution of generic drugs, OTC products, and other pharmaceutical products through the Company's distribution network across India. In domestic Marketing business, the Company procures finished dosage forms (FDFs) from domestic formulation manufactures and then market them under its portfolio of brands. It has a set of manufacturing partners recognized by the WHO with a rigorous focus on product quality. With a portfolio of more than 3000 products in various categories, such as generics, OTC products, allopathic, ayurvedic, etcetera, the Company cater to a variety of ailments. Currently, the Company has over 1050 distributors spread around the country. Instead of the Company directly engaging in sales, distribution, and promotion activities, its distributors engage in ethical marketing or other sales, distribution, and promotion activities on their own. Instead, it provide distributors directly with incentives to help them sell products more effectively.

Secondly, the exports business vertical started in 2010, following the establishment of formulations manufacturing facility in the Sachin SEZ. The Company is required to export products from this unit in accordance with the laws governing this SEZ. At present, it has product approvals in 30 countries, particularly in the semi-regulated and regulated markets in the African, Asian, CIS, and Latin American countries. In this facility, the Company make around 250 formulations for direct exports and contract manufacturing. . At present, the Company has 253 dossiers approved across multiple countries, and another 311 dossiers have been filed and are pending approval. It significantly increased efforts and investments towards product registration, the results of which are now apparent in the form of product approvals and expansion of export operations.

In the Retail Pharmacy Chain business vertical, the Company operates a chain of pharmacy stores under the brand - 'Davaindia'. Davaindia focuses only on private-label products in the medicinal, OTC, and ayurvedic categories, with a greater emphasis on chronic therapies and ailments. This concept started with three pilot stores in 2017 and has been scaled up to become the largest private-sector generic pharmacy chain with more than 591 stores as of March 2021. Davaindia operates on a unique asset-light franchise model for majority stores. These stores are engaged in exclusive sales of Davaindia products, with more than 95% of products being private-label.

In all areas and media, such as TV commercials, printing, digital & social media, radio, among others, the Company has undertaken bold and aggressive marketing and promotion activities with the firm intention of creating top-of-the-mind brand recall for Davaindia. Davaindia - being a front-runner in private sector generic pharmacy has also assumed the responsibility to create awareness, propagate virtues and debunk misconceptions about generic drugs. Marketing efforts are receiving very encouraging results from prospective franchisees and potential customers. The Company witnessed a substantial improvement in average wallet spend, footfall at stores, and the number of inquiries for new franchisees with aggressive marketing campaigns.

The Company has started a series of promotions, including TV and digital advertisements featuring Mr Kapil Dev. Mr Kapil Dev, as an icon, stands for integrity, excellence and willpower, the Company strongly feels he is the perfect fit for endorsing the culture and spirit of Davaindia and Zota Health Care Limited.

Zota Health Care Share Price

Zota Health Care share price reflects investor sentiment toward the company and is impacted by various factors such as financial performance, market trends, and economic conditions. Share price is an indicator which shows the current value of the company's shares at which buyers or sellers can transact.

Zota Health Care Market Cap

Market capitalization of Zota Health Care indicates the total value of its outstanding shares. Marketcap is calculated by multiplying share price and outstanding shares of the company. It is a helpful metric for assessing the company's size and market Valuation. It also helps investors understand how Zota Health Care is valued compared to its competitors.

Zota Health Care PE Ratio

Zota Health Care PE ratio helps investors understand what is the market value of each stock compared to Zota Health Care 's earnings. A PE ratio higher than the average industry PE could indicate an overvaluation of the stock, whereas a lower PE compared to the average industry PE could indicate an undervaluation.

Zota Health Care PEG Ratio

The PEG ratio of Zota Health Care evaluates its PE ratio in relation to its growth rate. A PEG ratio of 1 indicates a fair value, a PEG ratio of less than 1 indicates undervaluation, and a PEG ratio of more than 1 indicates overvaluation.

Zota Health Care ROE (Return on Equity)

Return on Equity (ROE) measures how effectively Zota Health Care generates profit from shareholders' equity. A higher ROE of more than 20% indicates better financial performance in terms of profitability.

Zota Health Care ROCE (Return on Capital Employed)

Return on Capital Employed (ROCE) evaluates the profitability of Zota Health Care in relation to its capital employed. In simple terms, ROCE provides insight to investors as to how well the company is utilizing the capital deployed. A high ROCE of more than 20% shows that the business is making profitable use of its capital.

Zota Health Care Total Debt

Total debt of Zota Health Care shows how much the company owes to either banks or individual creditors. In simple terms, this is the amount the company has to repay. Total debt can be a very useful metric to show the financial health of the company. Total debt more than equity is considered to be a bad sign.

Zota Health Care Debt to Equity Ratio

The Debt-to-Equity (DE) ratio of Zota Health Care compares its total debt to shareholders' equity. A higher Debt to Equity ratio could indicate higher financial risk, while a lower ratio suggests that the company is managing its debt efficiently.

Zota Health Care CAGR (Compound Annual Growth Rate)

CAGR shows the consistent growth rate of Zota Health Care over a specific period, whether it is over a month, a year, or 10 years. It is a key metric to evaluate the company’s long-term growth potential. Main metrics for which CAGR is calculated are net sales, net profit, operating profit, and stock returns.

Zota Health Care Technical Analysis

Technical analysis of Zota Health Care helps investors get an insight into when they can enter or exit the stock. Key components of Zota Health Care Technical Analysis include:

Support Levels (S1, S2, S3)

There are usually multiple support levels, but the main support levels for a stock are S1, S2, S3. Support levels indicate price points where stock might get support from buyers, helping the stock stop falling and rise.

Resistance Levels (R1, R2, R3)

There are usually multiple resistance levels, but the main resistance levels for a stock are R1, R2, R3. Resistance levels represent price points where Zota Health Care shares often struggle to rise above due to selling pressure.

Zota Health Care Dividends

Dividends refer to the portion of the company’s profits distributed to its shareholders. Dividends are typically paid out in cash and reflect Zota Health Care ’s financial health and profitability.

Zota Health Care Bonus Shares

Bonus shares are usually given by companies to make the stock more affordable, increase liquidity, boost investor confidence, and more.

Zota Health Care Stock Split

Stock split increases the number of its outstanding shares by dividing each existing share into multiple shares. When the company offers a stock split, the face value of the stock reduces in the same proportion as the split ratio.

Zota Health Care Financials

The financials of Zota Health Care provide a complete view to investors about its net sales, net profit, operating profits, expenses, and overall financial health. Investors can analyze financial data to assess the company’s stability and also understand how the company has been growing financially.

Zota Health Care Profit and Loss Statements

The profit and loss statement of Zota Health Care highlights its net sales, net profit, total expenditure, and operating profits in the current financial year. This Profit and Loss statement is crucial for evaluating the profitability and financial stability of Zota Health Care .

Zota Health Care Balance Sheet

The balance sheet presents a snapshot of Zota Health Care ’s assets, liabilities, and equity of shareholders, providing insights into the financials of the company.

Zota Health Care Cashflow Statements

Cashflow statements track the company's cash inflows and outflows over a period. It is an essential tool for understanding how well the company manages its liquidity and finances.

Download the App

Download the App